WCRI reports for Delaware and Philadelphia reported increases, matching patterns seen previously in other states.
WCRI reports for Delaware and Philadelphia reported increases, matching patterns seen previously in other states.
Dermatologicals represent a significant and growing portion of workers’ comp spend and come with cost and efficacy considerations.
An infographic breakdown of the diverse drug categories that comprise dermatological prescribing and spend.
A new report from the CWCI highlights trends in dermatologicals, opioids, and antidepressants.
With opioid utilization down, there is no longer a consolidated driver of pharmacy costs in workers’ comp. Here are four drug classes driving pharmacy costs today.
As opioid prescribing continues to decline, more nuanced and population-specific drug trends emerge as cost drivers.
WCRI explores how drug payments varied across 28 states for key drug therapy groups.
